Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (375 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 11 Dec 2025 – 20 Aug 2026, limited by DSP Nifty Midcap 150 Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | DSP Nifty Midcap 150 Index Fund | Nifty Midcap 150 |
|---|---|---|
| 11 Dec 2025 | ₹100.00 | ₹100.00 |
| 01 Jan 2026 | ₹102.13 | ₹101.75 |
| 22 Jan 2026 | ₹97.59 | ₹97.64 |
| 12 Feb 2026 | ₹101.63 | ₹101.64 |
| 05 Mar 2026 | ₹97.43 | ₹97.41 |
| 26 Mar 2026 | ₹93.15 | ₹93.17 |
| 16 Apr 2026 | ₹99.40 | ₹99.49 |
| 07 May 2026 | ₹104.04 | ₹104.16 |
| 28 May 2026 | ₹104.42 | ₹104.53 |
| 18 Jun 2026 | ₹104.49 | ₹104.57 |
| 09 Jul 2026 | ₹104.35 | ₹104.40 |
| 30 Jul 2026 | ₹105.23 | ₹105.20 |
| 20 Aug 2026 | ₹106.90 | ₹106.83 |
| Metric | DSP · Direct NAV ₹10.69 Very High risk Unrated | Category median Index Funds · 375 funds |
|---|---|---|
| — | +5.66% | |
| — | +8.82% | |
| — | +9.15% | |
| — | +11.72% | |
| +6.90% | +7.67% | |
| +18.22% | — | |
| — | +12.67% | |
| — | +13.64% | |
| — | +12.84% | |
| Risk | ||
| 17.89% | 13.97% | |
| — | 0.24 | |
| — | 0.36 | |
| -14.00% | -16.12% | |
| Nifty Midcap 150 | — | |
| — | +0.84% | |
| — | 1.00 | |
| — | 102.2% | |
| — | 97.2% | |
| 0.39% | 0.36% | |
| ₹13.72Cr | ₹177.09Cr | |
| None | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 16% | 35% | |
| Anil Ghelani | — | |
| 11 Dec 2025 | — | |
| 150 | — | |
| 18.2% | — | |
| 0.1% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.